Improving Quality through Introduction of Infection Control System in OT in Ibn Al Nafees - Essay Example

ere the healthcare professionals engaged in hospital care services are rendered restricted in terms of choice of antibiotics while treating these cases. This becomes more significant in operating theaters. For example, strains of Staphylococcus aureus that are resistant to methicillin and multiple other antibiotics are endemic in numerous hospital environments, leaving vancomycin as the sole effective antimicrobial agent for many patients infected with this microorganism. The majority of these clinical isolates being methicillin resistant coagulase-negative Staphylococci, there had been increasing reliance on vancomycin for surgical prophylaxis.

In no time, there were reports of emerging strains of vancomycin-resistant enterococci. This indicates that choosing newer antibiotics is not the appropriate approach to handle such situations. To add to this problem, in the hospital environment, there are increasing incidences of infections with poly-antimicrobial resistant strains of different other common hospital-acquired strains such as Pseudomonas, other Gram-negative bacilli, and enterobacteriaceae. They are increasingly resistant to more frontline antimicrobials, such as quinolones, aminoglycosides, monobactams, and third-generation cephalosporins.

This culminates into a situation where nosocomial infections occur, but the care professionals are left with no options for treatment in the hospitalisation settings, which faces absolute erosion in the efficacy of even the newest antimicrobial agents mainly due to very rapid emergence of resistance. Failure to treat such conditions in the postsurgical patients would lead to situations involving longer hospital stay, increased morbidity or mortality, stakeholder dissatisfaction, and increased financial consequences for both the hospital and the clients (Curran, 2001).

It indicates that the best way to get rid of these infections is to prevent them, since the other therapeutic eradication measures lead to morbidity,